+ Watch ITMN
on My Watchlist
The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology.
There are currently 14500 ITMN shares in my "fund" with break-even of around 8.70 USD. http://caps.fool.com/Blogs/fund-trades/678775.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions